KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,735,540 | -86.6% | 10,264 | -82.9% | 0.00% | -75.0% |
| Q2 2023 | $12,997,338 | +91.3% | 59,937 | +73.3% | 0.00% | +33.3% |
| Q4 2022 | $6,795,167 | -36.8% | 34,581 | -27.7% | 0.00% | -40.0% |
| Q3 2022 | $10,757,000 | +1941.2% | 47,824 | +1048.2% | 0.01% | – |
| Q2 2022 | $527,000 | -94.6% | 4,165 | -94.6% | 0.00% | -100.0% |
| Q1 2022 | $9,767,000 | +72.7% | 77,035 | +78.5% | 0.00% | +50.0% |
| Q4 2021 | $5,654,000 | +1185.0% | 43,158 | +1098.8% | 0.00% | – |
| Q3 2021 | $440,000 | -17.9% | 3,600 | -23.4% | 0.00% | – |
| Q2 2021 | $536,000 | -49.3% | 4,700 | -46.6% | 0.00% | – |
| Q1 2021 | $1,058,000 | -35.1% | 8,800 | -45.2% | 0.00% | – |
| Q4 2020 | $1,630,000 | +33.0% | 16,048 | +1.2% | 0.00% | -100.0% |
| Q3 2020 | $1,226,000 | -81.2% | 15,863 | -72.9% | 0.00% | -75.0% |
| Q2 2020 | $6,517,000 | +710.6% | 58,467 | +447.8% | 0.00% | +300.0% |
| Q4 2019 | $804,000 | – | 10,673 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |